Randomized comparative trial of pegylated liposomal doxorubicin versus bleomycin and vincristine in the treatment of AIDS-related Kaposi's sarcoma. International Pegylated Liposomal Doxorubicin Study Group.

Randomized comparative trial of pegylated liposomal doxorubicin versus bleomycin and vincristine in the treatment of AIDS-related Kaposi's sarcoma. International Pegylated Liposomal Doxorubicin Study Group.

Item

http://www.wikidata.org/entity/Q34745283

Q34745283

about

Treatment of severe or progressive Kaposi's sarcoma in HIV-infected adults Treatment of Kaposis sarcoma in HIV-1 infected individuals with emphasis on resource poor settings Ethics in nanomedicine Clinical Translation of Nanomedicine.Safety and efficacy of pegylated liposomal doxorubicin in HIV-associated Kaposi's sarcoma.Phase II study of carboplatin and liposomal doxorubicin in patients with recurrent squamous cell carcinoma of the cervix.Cardiotoxicity of cancer therapy.Update on KSHV epidemiology, Kaposi Sarcoma pathogenesis, and treatment of Kaposi Sarcoma.Pegylated liposomal doxorubicin: metamorphosis of an old drug into a new form of chemotherapy.Randomized trial of paclitaxel versus pegylated liposomal doxorubicin for advanced human immunodeficiency virus-associated Kaposi sarcoma: evidence of symptom palliation from chemotherapy.Liposomally targeted cytotoxic drugs for the treatment of cancer.Metastatic Kaposi's Sarcoma with Perirectal Involvement Diagnosed with Endoscopic Ultrasound-Guided EchoBrush Cytology Sampling.Excellent clinical outcomes and retention in care for adults with HIV-associated Kaposi sarcoma treated with systemic chemotherapy and integrated antiretroviral therapy in rural Malawi Potent antiviral activity of topoisomerase I and II inhibitors against Kaposi's sarcoma-associated herpesvirus Novel pharmacological therapies for the treatment of AIDS-related Kaposi's sarcoma.Design considerations for liposomal vaccines: influence of formulation parameters on antibody and cell-mediated immune responses to liposome associated antigens A Prospective Study Assessing Tumour Response, Survival, and Palliative Care Outcomes in Patients with HIV-Related Kaposi's Sarcoma at Queen Elizabeth Central Hospital, Blantyre, Malawi.Therapeutic options for human herpesvirus-8/Kaposi's sarcoma-associated herpesvirus-related disorders.Gastrointestinal Kaposi's sarcoma: Case report and review of the literature.Phase II study of bevacizumab in patients with HIV-associated Kaposi's sarcoma receiving antiretroviral therapy.Trends in Kaposi's Sarcoma in Miami Beach from 1987 to 2007 Pulmonary Kaposi's sarcoma as the initial presentation of human immunodeficiency virus infection.Role of pegylated lyposomal doxorubicin (PLD) in systemic Kaposi's sarcoma: a systematic review.Synthesis and biological response of size-specific, monodisperse drug-silica nanoconjugates.Biodistribution and pharmacokinetics of 111In-DTPA-labelled pegylated liposomes in a human tumour xenograft model: implications for novel targeting strategies.Targeted radiosensitisation by pegylated liposome-encapsulated 3', 5'-O-dipalmitoyl 5-iodo-2'-deoxyuridine in a head and neck cancer xenograft model.Phase I clinical trial and pharmacokinetic evaluation of NK911, a micelle-encapsulated doxorubicin.Anthracycline-induced cardiotoxicity: course, pathophysiology, prevention and management.A phase I study of liposomal-encapsulated docetaxel (LE-DT) in patients with advanced solid tumor malignancies.Liposomal daunorubicin as treatment for Kaposi's sarcoma Kaposi Sarcoma of Childhood: Inborn or Acquired Immunodeficiency to Oncogenic HHV-8 Mind the gap: a survey of how cancer drug carriers are susceptible to the gap between research and practice.Targeted therapy for Kaposi sarcoma.Hepatic Kaposi sarcoma: A case report and review of the literature.Application of pharmacokinetic and pharmacodynamic analysis to the development of liposomal formulations for oncology.New drug targets in Kaposi sarcoma.Pharmacological management of Kaposi's sarcoma.Advances in the systemic treatment of cutaneous sarcomas.Studying Rac1-induced tumorigenesis suggests antioxidants may help prevent and treat Kaposi's sarcoma.Primary cardiac angiosarcoma.

P2860

Q24193874-E955C4A8-E265-4BAA-988B-495A3C3179D5 Q24247970-DF626E7D-F98D-4C26-84BC-F11F4FEED06D Q28389241-330D0221-6203-4D7A-A1A1-CE45DA3583DF Q30355939-B5A16968-70E0-458E-8129-CD8FFBD16CB3 Q30380999-899CC618-BB66-4475-BE80-0A081C978791 Q33340188-13417C71-5203-43F0-80D8-38280C913DC4 Q33704056-363CFD05-4A57-47F4-BB9B-7B2C913E7CDC Q34168712-9EB47AB3-4D8F-4DDF-A4D3-42535E7CD67F Q34280875-23D0D7D5-8B23-4FBB-A6E1-9AC23C67DDDB Q34620787-F97C02D7-3E94-4258-8EA2-2D1787341AEE Q35051019-A3534E50-B1CC-4291-B9B9-50B81D290468 Q35149879-F90C3B48-AE38-421E-9550-90FF38D33FC5 Q35668862-5267801D-5B47-4569-9A73-0A265509DD8B Q35689364-7A19604C-0BAC-4765-A935-FB551255EA84 Q35779249-01B072F9-A0E0-4CE5-83B7-83A3B69839A5 Q35812875-9F5BBEA6-DA76-43A9-95B8-AD68A00C965C Q35846173-A92A0F91-4002-453C-ABF0-F205E504C645 Q35917368-6063259D-415F-4834-9772-672BB1165202 Q35922027-C8F2527E-B4E1-41FC-A564-56EF0BA79EBB Q36058281-1BBEBD33-54D2-4F61-92F2-0A4F9A61AB7C Q36520006-E63DA3E3-A4CF-454A-8B1A-598BA305A777 Q36526390-7A3EBA87-A3DD-4E79-BE7E-09490A945EEF Q36532263-9ED6D120-1DC2-4A64-A9EB-1A3B5E8ADEDC Q36562731-6DD62ECE-D870-45C8-A657-FAC8F4BBC440 Q36621692-DA2C05F0-D97B-44D6-BA22-C7EC4EB4C790 Q36695358-BBE019D4-0D68-490B-9E93-052096EE0ABC Q36696233-A1FDB758-9737-4632-83AE-9642158B4FE2 Q36828128-55E206E6-D783-4FAB-882F-2328033016FB Q36988072-06F3F6E9-FDFB-4ECD-BB63-A70954C261D2 Q37004096-4474A13A-C7D3-4376-B5AB-2505BD99163A Q37173586-5D823590-B758-4113-8E07-96EB0D870AA6 Q37467770-A8ED1F3B-CB5F-416C-BF30-D550C8E59204 Q37505000-43B6E7CC-B84A-4CBF-9C9B-0FE7E729CEA9 Q37628536-61EA3528-1CF7-43A0-ADFA-42230F2F5D97 Q37689857-CCD8D8EF-4DAC-4FB3-BAFF-1EFD0C589899 Q37806235-6165FCA4-AEFE-4294-B37F-CED4C68A4F01 Q37868566-E9AA911E-A53A-4F45-A500-5FC6694278F9 Q38000872-C5B4FD9C-0B85-4CF0-9AFE-E0A43565B003 Q39942917-1FD35B6C-9149-4B5B-B00F-3296974D28AA Q41060673-0FA26CC0-A325-4EE2-A77A-4D30A4BFD449

P2860

Randomized comparative trial of pegylated liposomal doxorubicin versus bleomycin and vincristine in the treatment of AIDS-related Kaposi's sarcoma. International Pegylated Liposomal Doxorubicin Study Group.

Item

http://www.wikidata.org/entity/Q34745283

description

1998 nî lūn-bûn

@nan

1998 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

1998 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

1998年の論文

@ja

1998年論文

@yue

1998年論文

@zh-hant

1998年論文

@zh-hk

1998年論文

@zh-mo

1998年論文

@zh-tw

1998年论文

@wuu